Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 499 entries
View as:

Clinical Research on Shenfu Injection in Septic Patients

Phase: N/A Priority: Normal
NCT ID: NCT06157320 Org: User:
Start: 12/01/23 End: 01/01/26 Due: 01/01/27

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04384601 Org: User:
Start: 09/30/21 End: 09/30/27 Due: 09/30/28

Impact of PEEP Trials on Ventilation-Perfusion Matching in ARDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT06823804 Org: User:
Start: 11/01/22 End: 11/01/25 Due: 11/01/26

The Optimal Sequence in Same-day Bidirectional Endoscopy Under Deep Anesthesia.

Phase: N/A Priority: Normal
NCT ID: NCT04973878 Org: User:
Start: 07/30/21 End: 07/30/22 Due: 07/30/23

Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - I

Phase: N/A Priority: Normal
NCT ID: NCT05884008 Org: User:
Start: 05/01/23 End: 12/31/25 Due: 12/31/26

The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults

Phase: N/A Priority: Normal
NCT ID: NCT06876701 Org: User:
Start: 04/01/25 End: 04/01/27 Due: 04/01/28

TReanscAtheter TreatMent of PurE Aortic Regurgitation with VitaFlow Liberty System

Phase: N/A Priority: Normal
NCT ID: NCT06818084 Org: User:
Start: 02/01/25 End: 11/30/27 Due: 11/30/28

Asymmetric Targeted DBS for PD With PIGD

Phase: N/A Priority: Normal
NCT ID: NCT05397340 Org: User:
Start: 09/01/22 End: 12/31/24 Due: 12/31/25

Risk Factors for Predictors of MACEs After RA-CABG

Phase: N/A Priority: Normal
NCT ID: NCT04935086 Org: User:
Start: 06/30/21 End: 11/30/21 Due: 11/30/22

Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06876688 Org: User:
Start: 11/30/23 End: 11/30/28 Due: 11/30/29

Real-World Study of DLBCL With Different Genetic Subtypes

Phase: N/A Priority: Normal
NCT ID: NCT06026488 Org: User:
Start: 10/01/23 End: 12/31/26 Due: 12/31/27

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06795113 Org: User:
Start: 06/01/13 End: 12/31/29 Due: 12/31/30

Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02201771 Org: User:
Start: 07/31/14 End: 01/31/17 Due: 01/31/18

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Phase: N/A Priority: Normal
NCT ID: NCT05899621 Org: User:
Start: 06/01/23 End: 06/30/27 Due: 06/30/28

Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04781413 Org: User:
Start: 03/01/21 End: 03/01/24 Due: 03/01/25

Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05792254 Org: User:
Start: 05/31/23 End: 05/31/25 Due: 05/31/26

Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

Phase: N/A Priority: Normal
NCT ID: NCT03913312 Org: User:
Start: 09/01/18 End: 09/30/22 Due: 09/30/23

A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin's Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03930043 Org: User:
Start: 03/01/17 End: 12/31/20 Due: 12/31/21

Conventional Laparoscopic APR Versus Laparoscopic APR With Transabdominal Individualized Levator Transection

Phase: N/A Priority: Normal
NCT ID: NCT02812628 Org: User:
Start: 12/31/12 End: 06/30/22 Due: 06/30/23

A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice

Phase: N/A Priority: Normal
NCT ID: NCT06541340 Org: User:
Start: 08/01/24 End: 12/31/26 Due: 12/31/27

Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06788600 Org: User:
Start: 04/01/25 End: 10/31/26 Due: 10/31/27

A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06494371 Org: User:
Start: 07/31/24 End: 08/31/28 Due: 08/31/29

Real-world Study of Acalabrutinib

Phase: N/A Priority: Normal
NCT ID: NCT06767891 Org: User:
Start: 07/02/24 End: 01/30/28 Due: 01/30/29

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Phase: N/A Priority: Normal
NCT ID: NCT06646666 Org: User:
Start: 12/01/24 End: 12/01/27 Due: 12/01/28

Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04400357 Org: User:
Start: 06/15/20 End: 11/30/22 Due: 11/30/23